These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1375 related articles for article (PubMed ID: 26557954)
1. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954 [TBL] [Abstract][Full Text] [Related]
2. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197 [No Abstract] [Full Text] [Related]
3. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181 [TBL] [Abstract][Full Text] [Related]
5. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355 [TBL] [Abstract][Full Text] [Related]
6. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort. De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068 [TBL] [Abstract][Full Text] [Related]
7. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ; JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177 [TBL] [Abstract][Full Text] [Related]
9. Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Sargent R; Hawkins C; Sourianarayanane A; Khiyami A; Yerian L; Pai RK; Dasarathy S; McCullough AJ BBA Clin; 2015 Jun; 3():141-5. PubMed ID: 26675585 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Verma S; Jensen D; Hart J; Mohanty SR Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360 [TBL] [Abstract][Full Text] [Related]
11. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133 [TBL] [Abstract][Full Text] [Related]
13. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590 [TBL] [Abstract][Full Text] [Related]
14. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
15. acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study. Wu XX; Zheng KI; Boursier J; Chan WK; Yilmaz Y; Romero-Gómez M; El Kassas M; Targher G; Byrne CD; Huang ZM; Zheng MH EClinicalMedicine; 2021 Nov; 41():101145. PubMed ID: 34646997 [TBL] [Abstract][Full Text] [Related]
16. Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? Türker F; Oral A; Şahin T; Türker BÇ; Koçak E; Ataoğlu HE; Ahbab S J Int Med Res; 2021 Nov; 49(11):3000605211056841. PubMed ID: 34763561 [TBL] [Abstract][Full Text] [Related]
17. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110 [TBL] [Abstract][Full Text] [Related]
18. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902 [TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients. Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071 [TBL] [Abstract][Full Text] [Related]
20. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]